Merck

Every New FDA Drug Approval in 2017
Every New FDA Drug Approval in 2017The last 12 drugs approved in the year, along with the other 34.
Top 3 new drug approvalsHere are 3 of the top new drug approvals in late December and early January.
A Boxed Warning Goes Away
A Boxed Warning Goes AwayA rare removal of a box warning after large-scale clinical trials.
Ten ways multiple myeloma treatment is changingAs multiple myeloma treatment improvements continue, it’s important for managed care executives to get out in front of these 10 changes on the horizon.
GSK Launches More Effective Shingles Vaccine
GSK Launches More Effective Shingles VaccineWill Shingrix become the new go-to shingles vaccine?
FDA warns about deaths in cancer drug trials
FDA warns about deaths in cancer drug trialsAn increased risk of deaths for patients in clinical trials receiving this cancer drug and two other drugs led FDA to stop the clinical trials.
FDA Warning on KeytrudaAfter trials halted, FDA issues warning on off-label use of the drug.
Evolving hepatitis C pipeline offers hope to patients
Evolving hepatitis C pipeline offers hope to patientsCost burden prompts payers to consider appropriate utilization
FDA gives once-daily HIV therapy go-aheadFDA approves Isentress at a higher dose for HIV-1 infected patients.
Immuno-oncology bladder drug wins approvalSoon after approving the same drug for metastatic Merkel cell carcinoma, FDA approved immuno-oncology avelumab (Bavencio) for locally advanced or metastatic urothelial carcinoma.